In Malaysia, the high prevalence of smoking is a primary driver of the disease, with approximately 19 per cent of adults over ...
I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m dealing with the effects of it ...
Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...
In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...
Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.
Inhalers and nebulizers play a key role in delivering medication to the lungs, making it easier for people with breathing ...
Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...
GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala ...